10,000 volunteers: Novavax coronavirus vaccine enters late stage trials in UKChristian Fernsby ▼ | September 25, 2020
Novavax has announced it is starting its Phase 3 trial of an experimental coronavirus vaccine in the UK.
Half of the volunteers will receive two shots of NVX-CoV2373 with Matrix-M, Novavax's adjuvant, which is meant to strengthen the vaccine. The other participants will be given a placebo. ■